Ads
related to: glaxosmithkline
Search results
Marti Technologies names new CFO By Investing.com
Investing.com· 6 days agoMarti Technologies, Inc. (NYSE American: MRT), a prominent mobility service provider in Türkiye, today announced the appointment of Oguz Erkan as its new...
Tempus, Chicago's biotech darling, files to go public
Crain s Chicago Business· 3 days agoAfter several years of speculation Tempus would go public, the AI-enabled precision-medicine startup from Eric Lefkofsky filed for an initial public offering today. The company, founded in 2015 ...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
Reuters· 3 days ago, opens new tab has been sued by an independent Connecticut laboratory that accused the drugmaker of...
Tempus AI files to go public
Modern Healthcare· 3 days agoTempus declined to comment but plans for its stock to trade on the the Nasdaq Global Select Market under the ticker TEM. Tempus' database includes 7.7 million clinical records and is used by ...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk By Reuters
Investing.com· 3 days agoIn a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False Claims...
Court backs drugmakers in limiting 340B distribution
Becker’s Hospital Review· 2 days agoThree judges for the U.S. Court of Appeals for the Washington, D.C. Circuit ruled May 21 in favor of drug manufacturers' ability to limit sales and distribution of discounted drugs in the government's ...
AI Is Deciphering Your Corporate Trade Secrets
Forbes· 2 days agoIn the high-stakes world of corporate competition, trade secrets are the hidden gems that give companies their competitive edge. AI's ability to analyze, learn, and decipher complex patterns ...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Morningstar· 3 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both trials of depemokimab ...
